Results for tag: "Carperitide"

The Carperitide market is a subset of the cardiovascular drug market, focusing on drugs that target the renin-angiotensin-aldosterone system (RAAS). Carperitide is a synthetic peptide hormone that mimics the action of the natural hormone, angiotensin II, and is used to treat hypertension and heart failure. It is also used to reduce the risk of stroke, myocardial infarction, and other cardiovascular diseases. Carperitide is typically administered orally or intravenously, and is available in both generic and branded formulations. The Carperitide market is highly competitive, with a number of major pharmaceutical companies offering branded and generic versions of the drug. Some of the major players in the market include Novartis, Pfizer, Sanofi, Merck, and AstraZeneca. Show Less Read more